SUCAMPO PHARMACEUTICALS INC's ticker is SCMP and the CUSIP is 864909106. A total of 170 filers reported holding SUCAMPO PHARMACEUTICALS INC in Q2 2017. The put-call ratio across all filers is 0.56 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $899,000 | +17.5% | 50,100 | -22.7% | 0.05% | +14.3% |
| Q3 2017 | $765,000 | +8.5% | 64,800 | -3.4% | 0.04% | +5.0% |
| Q2 2017 | $705,000 | +20.1% | 67,100 | +25.7% | 0.04% | +17.6% |
| Q1 2017 | $587,000 | -16.5% | 53,400 | +2.9% | 0.03% | -22.7% |
| Q4 2016 | $703,000 | – | 51,900 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Krensavage Asset Management, LLC | 555,652 | $9,607,000 | 3.06% |
| OBERWEIS ASSET MANAGEMENT INC/ | 96,630 | $1,671,000 | 0.47% |
| JUNCTURE WEALTH STRATEGIES, LLC | 35,281 | $610,000 | 0.46% |
| AWM Investment Company, Inc. | 100,000 | $1,729,000 | 0.34% |
| GLOBEFLEX CAPITAL L P | 65,588 | $1,134,000 | 0.30% |
| NEW AMSTERDAM PARTNERS LLC/NY | 166,479 | $2,878,000 | 0.30% |
| Convergence Investment Partners, LLC | 100,850 | $1,744,000 | 0.20% |
| GSA CAPITAL PARTNERS LLP | 219,881 | $3,802,000 | 0.19% |
| OXFORD ASSET MANAGEMENT LLP | 433,219 | $7,672,000 | 0.18% |
| Zebra Capital Management LLC | 17,720 | $306,000 | 0.17% |